Clinical Sequencing

News on sequencing-based testing, NGS gene panels, & diagnostic exomes in genetics, genomics, and molecular diagnostics.

Sep 13, 2022

Pediatric Patients Face Barriers Receiving Exome Sequencing From Insurance, Scheduling Delays
Premium

Sep 8, 2022

Dante Genomics, TMA Precision Health Partner for Rare Disease Diagnostics

Sep 6, 2022

EU to Disallow Illumina's Grail Purchase

Sep 1, 2022

Illumina Says Judge Issued Favorable Decision in FTC Challenge to Grail Acquisition

Aug 30, 2022

Thermo Fisher Scientific Obtains CE-IVD Mark for Targeted NGS Oncology Test, Analysis Software

Aug 22, 2022

MDIC Launches Initiative to Improve Accuracy of Next-Generation Sequencing-Based Cancer Diagnostics

Aug 9, 2022

Predicine Receives CE-IVD Mark for Blood and Urine Liquid Biopsy Assay

Aug 4, 2022

Fulgent Genetics Q2 Revenues Fall 18 Percent on Declining COVID Business

Aug 4, 2022

Adaptive Biotechnologies Halts T-Detect Commercialization, Reports 13 Percent Q2 Revenue Growth
Premium

Jul 29, 2022

MicroGenDx Expanding Hospital Business Following Reimbursement Decision, Publications
Premium

Jul 28, 2022

Adaptive Biotech's ClonoSeq Gets Expanded Medicare Coverage For B-Cell Lymphoma

Jul 25, 2022

Pair of Lab Owners Agree to Pay $5.7M to Settle Federal Fraud Allegations

Jul 25, 2022

China NMPA Approves GeneMind GenoCare 1600 Sequencer for Noninvasive Prenatal Testing

Jul 21, 2022

Imagia Canexia Health, Anwa Medical Partner to Offer Liquid Biopsy in Middle East, North Africa

Jul 19, 2022

Geneseeq, Brazil’s Hospital de Base Partner to Build Sequencing Lab for Cancer Patient Testing

Jul 18, 2022

MGI Tech, Burning Rock Biotech Join Forces to Develop Precision Oncology Products

Jun 20, 2022

Avesthagen, Wipro to Develop NGS-Based Disease Panels Under Strategic Alliance

Jun 15, 2022

Thermo Fisher Scientific Receives CE-IVD Mark for NGS Aneuploidy Diagnostic Software Workflows

Jun 13, 2022

Labcorp NGS Test for Identifying SARS-CoV-2 Strains Receives FDA EUA

Jun 6, 2022

New ESHG Recommendations for Clinical Whole-Genome Sequencing Show Differences From US Guidelines
Premium